ZyVersa Therapeutics's market cap is currently $1.20M. The company's EPS TTM is $-0.46; its P/E ratio is ―; ZyVersa Therapeutics is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
